Athos Bousvaros, MD, MPH
Vice Chair of Clinical Operations, Department of Pediatrics
Professor of Pediatrics, Harvard Medical School
Image
Athos Bousvaros, MD, MPH
Vice Chair of Clinical Operations, Department of Pediatrics
Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
Duke University School of Medicine
1985
Durham
NC
Internship
Duke University Hospital
1986
Durham
NC
Residency
Duke University Hospital
1988
Durham
NC
Fellowship
Boston Children's Hospital
1991
Boston
MA
Fellowship
Clinical Research/Pediatric Gastroenterology and Nutrition
Boston Combined Residency Program (BCRP)
1991
Boston
MA
Media
Caregiver Profile
Meet Dr. Athos Bousvaros
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Gastroenterology)
Professional History
Athos Bousvaros MD, MPH is a pediatric gastroenterologist who has worked at Boston Children’s Hospital for over 25 years. He completed his undergraduate degree at Williams College, his medical degree and residency at Duke University, and his gastroenterology fellowship at Boston Children's Hospital, Massachusetts General Hospital, and Harvard Medical School. As Associate Director of the Inflammatory Bowel Disease program at Boston Children's Hospital, he spends much of his time treating complex cases of Crohn’s disease and ulcerative colitis referred from across the country. His research interests include identifying the cause of IBD by studying the intestinal microbiome, developing new therapies for IBD, and examining the immune response of IBD patients to immunizations. He has over 100 original and review publications in medical literature.
He has served as Chair of the Chapter Medical Advisory Committee of the New England Crohn’s and Colitis Foundation of America and Chair of the CCFA Pediatric Affairs committee. He has also served as President of the North American Society for Pediatric GI and Nutrition (NASPGHAN), where he helped lead a campaign to promote child safety by getting high powered magnets out of the hands of toddlers. When not busy caring for patients or doing research, he enjoys developing patient education materials for children with chronic illness. These include the medical comics: “Pete Learns All About Crohn’s and Colitis” (with the CCFA), “Amy Goes Gluten Free,” “JD Shapes Up,” and “Sophie’s Science Project.” He has also co-authored the NASPGHAN book “Your Child with Inflammatory Bowel Disease.”
Approach to Care
Medicine combines science with art and knowledge with compassion. I followed my father's footsteps and became a physician because I saw how rewarding his career was (he still practices medicine at age 86). By working at Boston Children's Hospital, I not only get to help people day to day, but am also able to participate in studies that will help us find the causes and cures of Inflammatory Bowel Disease.
Publications
Clinical outcomes of maintenance therapy with sulfasalazine compared to 5-aminosalicylates in children with ulcerative colitis. View Abstract
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease. View Abstract
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease. View Abstract
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease. View Abstract
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease. View Abstract
Cytomegalovirus Colitis in a Patient With Ulcerative Colitis With Loss of Corticosteroid Response Upon Upadacitinib Initiation. View Abstract
Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease. View Abstract
Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease. View Abstract
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease. View Abstract
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease. View Abstract
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease. View Abstract
Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease. View Abstract
Collaborative Registries for Pediatric Crohn's Disease: A Leap Forward or More of the Same? View Abstract
Comparing Gastrointestinal Endoscopy Findings in Children with Autism, Developmental Delay, or Typical Development. View Abstract
Endoscopy of the Ileal Pouch Anal Anastomosis. View Abstract
Reply. View Abstract
Helicobacter pylori Antimicrobial Resistance Using Next-Generation Sequencing in Stool Samples in a Pediatric Population. View Abstract
Treatment of Genital Crohn's Disease With Upadacitinib in a Male Child: A Case Report. View Abstract
Efficacy and Safety of Tacrolimus or Infliximab Therapy in Children and Young Adults With Acute Severe Colitis. View Abstract
Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial. View Abstract
Helicobacter pylori Antimicrobial Resistance in a Pediatric Population From the New England Region of the United States. View Abstract
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. View Abstract
How to Write an Effective Letter of Medical Necessity. View Abstract
Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after Fecal Microbiota Transplant in Inflammatory Bowel Disease. View Abstract
Efficacy and Safety of Sulfasalazine Suspension in Children With Ulcerative Colitis. View Abstract
Development and Validation of the TUMMY-UC: A Patient-Reported Outcome for Pediatric Ulcerative Colitis. View Abstract
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. View Abstract
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease. View Abstract
Clinical Phenotypes and Outcomes in Monogenic Versus Non-monogenic Very Early Onset Inflammatory Bowel Disease. View Abstract
Denials, Dilly-dallying, and Despair: Navigating the Insurance Labyrinth to Obtain Medically Necessary Medications for Pediatric Inflammatory Bowel Disease Patients. View Abstract
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases. View Abstract
Lessons From a Quality Improvement Project to Standardize the Process of Gastric Biopsy Culture for Helicobacter pylori. View Abstract
Agreement on Symptoms Between Children With Ulcerative Colitis and Their Caregivers: Towards Developing the TUMMY-UC. View Abstract
Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease. View Abstract
Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. View Abstract
The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease. View Abstract
Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. View Abstract
Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease. View Abstract
The pharmacotherapeutic management of pediatric Crohn's disease. View Abstract
Natural history of children with mild Crohn's disease. View Abstract
Commentary: Monitoring Thiopurine Efficacy Without Levels: Is It a Good Idea? View Abstract
Microscopic/"Backwash" Ileitis and Its Association With Colonic Disease in New Onset Pediatric Ulcerative Colitis. View Abstract
Challenges in IBD Research: Pragmatic Clinical Research. View Abstract
Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary. View Abstract
Microscopic / "Backwash" Ileitis and its Association with Colonic Disease in New Onset Pediatric Ulcerative Colitis. View Abstract
Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD. View Abstract
Reducing Redundant Anaerobic Therapy Through Spaced Education and Antimicrobial Stewardship Interventions. View Abstract
Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis. View Abstract
Curved planar reformatting and convolutional neural network-based segmentation of the small bowel for visualization and quantitative assessment of pediatric Crohn's disease from MRI. View Abstract
The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease. View Abstract
Educational needs in the diagnosis and management of pediatric functional constipation: a US survey of specialist and primary care clinicians. View Abstract
Commentary: Button Batteries in Fidget Spinners: Is It Time to Push the "Panic Button"? View Abstract
Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in Children. View Abstract
Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial. View Abstract
Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab. View Abstract
Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. View Abstract
Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. View Abstract
Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis. View Abstract
Outcomes From Pediatric Gastroenterology Maintenance of Certification Using Web-based Modules. View Abstract
From "Jarts" to "Zen Magnets": Protecting Our Children from Dangerous Toys. View Abstract
O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis. View Abstract
Effect of Psychotherapy on Health Care Utilization in Children With Inflammatory Bowel Disease and Depression. View Abstract
Interleukin 1ß Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. View Abstract
Postoperative Complications in Children With Crohn Disease Treated With Infliximab. View Abstract
Longitudinal Patterns of Thalidomide Neuropathy in Children and Adolescents. View Abstract
NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-a Inhibitors. View Abstract
O-017 YI Inflammatory Versus Non-inflammatory Predictors of Specific Depressive Symptoms in a Large Pediatric Cohort with IBD. View Abstract
Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders. View Abstract
Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug. View Abstract
Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease. View Abstract
Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. View Abstract
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease. View Abstract
Surgical management and morbidity of pediatric magnet ingestions. View Abstract
Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease. View Abstract
Functional significance of single nucleotide polymorphisms in the lactase gene in diverse US patients and evidence for a novel lactase persistence allele at -13909 in those of European ancestry. View Abstract
Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD. View Abstract
Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study. View Abstract
Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. View Abstract
Benefit/risk assessment of biologic monotherapy vs combination therapy in Crohn's Remains Challenging. View Abstract
Pediatric ulcerative colitis: a practical guide to management. View Abstract
The effect of immunomodulators and biologics on indication for surgical bowel resection in children with Crohn's disease. View Abstract
Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy. View Abstract
Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. View Abstract
Authors' response. View Abstract
Predictors of depression in youth with Crohn disease. View Abstract
Depression subtypes in pediatric inflammatory bowel disease. View Abstract
Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. View Abstract
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. View Abstract
Advocating for child health: how the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition took action against high-powered magnets. View Abstract
NASPGHAN single-topic symposium: discovering the future of pediatric IBD care. View Abstract
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. View Abstract
Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. View Abstract
Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. View Abstract
Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease. View Abstract
Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis. View Abstract
Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. View Abstract
Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. View Abstract
The overlap of functional abdominal pain in pediatric Crohn's disease. View Abstract
Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum. View Abstract
Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis. View Abstract
Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. View Abstract
Management of ingested magnets in children. View Abstract
Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms. View Abstract
Characterization of fast and slow diffusion from diffusion-weighted MRI of pediatric Crohn's disease. View Abstract
Budesonide use in pediatric Crohn disease. View Abstract
A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. View Abstract
Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. View Abstract
An i2b2-based, generalizable, open source, self-scaling chronic disease registry. View Abstract
Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factor. View Abstract
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. View Abstract
Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. View Abstract
Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort. View Abstract
"Tac"kling a difficult problem: using tacrolimus to maintain remission in ulcerative colitis. View Abstract
Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores. View Abstract
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. View Abstract
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. View Abstract
Innate and adaptive immune connections in inflammatory bowel diseases. View Abstract
Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis. View Abstract
Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. View Abstract
Use of immunomodulators and biologic therapies in children with inflammatory bowel disease. View Abstract
Factors that determine risk for surgery in pediatric patients with Crohn's disease. View Abstract
Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy. View Abstract
Outcome following infliximab therapy in children with ulcerative colitis. View Abstract
Probiotic for new onset ulcerative colitis in children: baby's got bac(teria). View Abstract
Monitoring Disease Activity in Pediatric IBD Patients (monograph). Children's Digestive Health and Nutrition Foundation 2009
View Abstract
Healthcare burden of inflammatory bowel disease in the United States: more than pain and diarrhea. View Abstract
Restorative proctocolectomy and ileal pouch-anal anastomosis in children. View Abstract
Immunizations in patients with inflammatory bowel disease. View Abstract
Variation in care in pediatric Crohn disease. View Abstract
Appraisal of the pediatric ulcerative colitis activity index (PUCAI). View Abstract
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. View Abstract
Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. View Abstract
Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. View Abstract
Immune response to influenza vaccine in children with inflammatory bowel disease. View Abstract
Making the right diagnosis: differentiating between Crohn disease and ulcerative colitis in children and young adults.
View Abstract
Approach to clinical diagnosis of inflammatory bowel disease View Abstract
Nutritional concerns in pediatric inflammatory bowel disease patients. View Abstract
Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. View Abstract
Cyclic vomiting syndrome in adults. View Abstract
Research and clinical challenges in paediatric inflammatory bowel disease. View Abstract
Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. View Abstract
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. View Abstract
Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. View Abstract
Challenges and progress in pediatric inflammatory bowel disease. View Abstract
Intercenter variation in initial management of children with Crohn's disease. View Abstract
Laboratory values for children with newly diagnosed inflammatory bowel disease. View Abstract
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. View Abstract
Pete Learns About Crohn's and Colitis View Abstract
Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. View Abstract
Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. View Abstract
Challenges in pediatric inflammatory bowel disease. View Abstract
Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. View Abstract
Effective advocacy for patients with inflammatory bowel disease: communication with insurance companies, school administrators, employers, and other health care overseers. View Abstract
Medical therapy for refractory pediatric Crohn's disease. View Abstract
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. View Abstract
The natural history of corticosteroid therapy for ulcerative colitis in children. View Abstract
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. View Abstract
Gastrointestinal issues in developmentally disabled children View Abstract
Current therapy of inflammatory bowel disease in children. View Abstract
Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. View Abstract
A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. View Abstract
Workshop report: prevention of postoperative recurrence in Crohn's disease. View Abstract
Pediatric inflammatory bowel disease: what children can teach adults. View Abstract
Normal homocysteine levels in a population of children with inflammatory bowel disease. View Abstract
A review of activity indices and end points for clinical trials in children with Crohn's disease. View Abstract
Probiotic Therapies: the crossroads of traditional and alternative medicine View Abstract
Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. View Abstract
Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. View Abstract
Mucosal healing in children with Crohn's disease: appropriate therapeutic goal or medical overkill? View Abstract
Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. View Abstract
Gastroenterology questions for the American Academy of Pediatrics PREP course. Available on www.pedialink.org View Abstract
Immunosuppressive therapies View Abstract
Pediatric Crohn's disease View Abstract
Ulcerative colitis View Abstract
Gastroenterologic and Liver Disorders View Abstract
Risk of early surgery for Crohn's disease: implications for early treatment strategies. View Abstract
Blocking lymphocyte adhesion: new treatment for sticky cases of Crohn disease? View Abstract
Isolated neonatal swallowing dysfunction: a case series and review of the literature. View Abstract
Nutritional therapy of inflammatory bowel disease View Abstract
Webcast: Crohn's and colitis Foundation - Management of IBD in special populations. Available on www.ccfa.org View Abstract
Feeding tubes View Abstract
Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. View Abstract
Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease. View Abstract
Blame Canada: growing questions about budesonide. View Abstract
Complementary medicine use in children and young adults with inflammatory bowel disease. View Abstract
Research agenda for pediatric gastroenterology, hepatology and nutrition: chronic inflammatory bowel disease. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation. View Abstract
Board review questions in pediatric gastroenterology for the American Academy of Pediatrics PREP the course. 16 Questions per year for 6 years (2002-2008) View Abstract
Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease. View Abstract
Inflammatory bowel disease associated with immune thrombocytopenic purpura in children. View Abstract
Multiple micronutrient deficiencies in a child fed an elemental formula. View Abstract
Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1. View Abstract
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. View Abstract
Thalidomide in gastrointestinal disorders. View Abstract
Epidemiology and diagnosis of inflammatory bowel disease View Abstract
The spectrum of pediatric gastroesophageal reflux. View Abstract
Oral tacrolimus treatment of severe colitis in children. View Abstract
Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. View Abstract
Allergic esophagitis in children: a clinicopathological entity. View Abstract
Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. View Abstract
Gastrointestinal Manifestations of Primary Immunodeficiencies View Abstract
Crohn's disease in children and adolescents View Abstract
Ulcerative Colitis in children and adolescents View Abstract
Gastrointestinal issues in the child with developmental disabilities View Abstract
Intraduodenal hematoma complicating intestinal biopsy: case reports and review of the literature. View Abstract
Minocycline-related autoimmune hepatitis: case series and literature review. View Abstract
Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. View Abstract
Serum leptin in children and young adults with inflammatory bowel disease. View Abstract
Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. View Abstract
Clinical outcome of ulcerative proctitis in children. View Abstract
Preventing relapse after surgery for Crohn's disease: where do we go from here? View Abstract
Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes. View Abstract
Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing. View Abstract
Gastroenterologic Disorders View Abstract
Immunosuppressive Agents in Gastrointestinal Disease View Abstract
Tacrolimus (FK-506) treatment of fulminant colitis in a child. View Abstract
Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. View Abstract
Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). View Abstract
Immunology and Gastrointestinal Disease View Abstract
Immunosuppressive Agents in Gastrointestinal Disease View Abstract
Immunosuppressive therapies in Pediatric Gastroenterology View Abstract
New immunotherapies and their potential for treatment of inflammatory bowel disease View Abstract
Immunology and Gastrointestinal Disease View Abstract
Basic gastrointestinal immunology View Abstract
Ringed esophagus: an association with esophagitis. View Abstract
Development of the Intestinal Mucosal Barrier View Abstract
Diarrhea in the Immunodeficient Host View Abstract
Abdominal Wall Defects View Abstract
Imaging of neuroblastoma: an overview. View Abstract
Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience. View Abstract
Locations